Ever thought of starting a company based on your research results? Or patenting your own research data? This is possible! This course shows you how. When scientific discoveries are developed for commercial application, success of entry into the market is dependent on many factors. Among these are intellectual property, indication selection, (pre)clinical testing and financial aspects.
This 2-week course is to get Master’s and PhD students familiar with the ideas and concepts behind the valorization of research ideas and technology. The course will give insights in the identification of research or research ideas that can be commercialized, performance of proof-of-concept validation, the road through patent protection of obtained results or technology, pre-seed financing of research, formation of a start-up company and the development of a product into the market. There will be seminars by a selection of top-notch speakers, ranging from researchers with starting spin-off companies, experts on grant writing, patenting, regulatory issues, as well as finance and venture capital, to captains of industry and CEOs of large and successful companies.
Questions that will be addressed are:
• What are the many factors involved in getting laboratory discovery to a novel approved medicine?
• How does big pharma and biotech industry access innovation?
• How do entrepreneurial universities contribute to innovation?
• Which party plays which role at all stages?
• What are the keys to success?
There will be 24 contact hours, including lectures, lecture repetitions and discussions by the course coordinators and a number of invited lecturers. These will include external experts on molecular diagnostics and regulatory affairs, VUmc colleagues with presentations on their own spin-off companies, and colleagues of the Technology Transfer Office on legal and patent issues. In addition, the course consists of independent learning on the basis of exploring literature and business reports on selected topics. All lectures will be preceded by formulation of expectations and followed by lecture repetition sessions. Next to classes and discussion sessions, there will be six assignments to elaborate in groups of 4-5 students. Reporting will take place by dedicated presentations or written reports. On the last day of the course, students will present a business plan for a start-up company.
There is a requirement for 90% attendance. There is no general exam.
Date: October 29 – November 9, 2018
Target audience: PhD students in oncology AMC, VUmc and NKI
Price: Free of charge
Organization: Prof. dr. Arjan Griffioen, Dr. Else Huijbers, Dr. Judy van Beijnum
Information: For any questions or need for extra information please contact email@example.com
Registration: This course is closed for registration